Be the first to review this item
Trombovazim increases the fibrinolytic activity of the blood, providing a direct fibrinolytic effect.
Fibrinolytic agent. Has a thrombolytic, anti-inflammatory and cardioprotective effect.
The mechanism of thrombolytic action is associated with the direct destruction of filaments of fibrin, which form the basic framework of the thrombus. The mechanism of anti-inflammatory action is associated with the effect on the oxidative function of blood neutrophils and tissue macrophages. The mechanism of cardioprotective action is associated with improved blood supply to the myocardium.
Trombovazim is a low-toxic drug.
Trombovazim does not reduce platelet levels and does not affect clotting time and bleeding time.
As an auxiliary in the complex therapy of chronic venous insufficiency.
With caution should be used in patients with polyvalent allergies, COPD, with the threat of bleeding from the esophagus, urolithiasis, with gastric ulcer and duodenal ulcer in remission.
Take inside for 30-40 minutes before meals at a dose of 800-1600 units per day in 2 divided doses. The maximum daily dose is 2000 units. The course of treatment is 20 days. If there is no effectiveness during the course of treatment, the patient should consult a doctor. If necessary, it is possible to conduct repeated courses on the recommendation of a doctor.
Important notice- the outer box design may vary before prior notice!
Someone from the USA - just purchased the goods:
Kartalaks intensive course 180 capsules